- Author:
Sung Ryeol KIM
1
;
Jae Hyun LEE
Author Information
- Publication Type:Review
- Keywords: Asthma; Biologic therapy; Precision medicine; Personalized medicine
- MeSH: Adrenal Cortex Hormones; Asthma*; Biological Factors*; Biological Therapy; Humans; Precision Medicine; Risk Reduction Behavior
- From:Allergy, Asthma & Respiratory Disease 2019;7(1):3-12
- CountryRepublic of Korea
- Language:Korean
- Abstract: Most treatment strategies for asthma currently include inhaled corticosteroids, with the addition of long-acting beta-2-agonists or leukotriene modifiers, if necessary. However, some patients may not respond to conventional treatment. A better understanding of the pathophysiology of asthma has recently led to the development of biological agents, which have shown promising results for symptom control and future risk reduction in severe asthmatics. This article reviews currently available biologic agents, introduces related studies, and describes the subgroup of patients benefitting from each of biologic agents in the view point of precision medicine.